Evidence Synthesis
KREBSBIO Sees Accelerating Gross Margin and Marginal Operating Leverage Amidst Decelerating Daily Volume and Close Price The company's quarterly Gross Margin accelerated to 97.97%, up from -8.65%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 14 Sept 2026, 01:49
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
KREBSBIO Sees Accelerating Gross Margin and Marginal Operating Leverage Amidst Decelerating Daily Volume and Close Price The company's quarterly Gross Margin accelerated to 97.97%, up from -8.65%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 97.97 % | -8.65 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -8.65 % | -55.85 | ▲ |
| REVENUE_GROWTH_YOY | 27.4 % | — | - |
| PRICE_CHANGE_PERCENT | -2.831 % | — | - |
| DAILY_VOLUME | 8,042 shares | 10,752 | ▼ |
| CLOSE_PRICE | 59.73 INR | 61.47 | ▼ |